Patients and partners lack knowledge of androgen deprivation therapy side effects

Urologic Oncology: Seminars and Original Investigations

Volumn 31, Issue 7, 2013, Pages 1098-1105

  Walker, Lauren M ^a,b   Tran, Susan ^a,b   Wassersug, Richard J ^d,e   Thomas, Bejoy ^b,c   Robinson, John W ^a,b,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b TOM BAKER CANCER CENTRE   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d DALHOUSIE UNIVERSITY   (Canada)

^e LA TROBE UNIVERSITY   (Australia)

Author keywords

Androgen deprivation therapy; Patient education; Prostate cancer

Indexed keywords

GONADORELIN AGONIST;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ANEMIA; ARTICLE; CHECKLIST; DEPRESSION; DIZZINESS; FEMALE; FRACTURE; GYNECOMASTIA; HAIR LOSS; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MUSCLE MASS; NAUSEA; OSTEOPOROSIS; PATIENT EDUCATION; PRIORITY JOURNAL; PRURITUS; QUESTIONNAIRE; WEIGHT GAIN;

ANDROGEN DEPRIVATION THERAPY; PATIENT EDUCATION; PROSTATE CANCER;

AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; ANEMIA; DEPRESSION; FEMALE; HUMANS; MALE; MEMORY DISORDERS; MIDDLE AGED; OSTEOPOROSIS; PATIENT EDUCATION AS TOPIC; PATIENT MEDICATION KNOWLEDGE; PROSTATIC NEOPLASMS; QUESTIONNAIRES; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL PARTNERS; SPOUSES;

EID: 84884675086     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2011.12.015     Document Type: Article

References (46)

1. Jones C.U., Hunt D., McGowan D.G., et al. Radiotherapy and short-term androgen deprivation for localized prostate cancer. New Engl J Med 2011, 365:107-118.
2. Nanda A., Chen M.H., Braccioforte M.H., et al. Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction. J Am Med Assoc 2009, 302:866-873.
3. Smith M.R. Androgen deprivation therapy for prostate cancer: New concepts and concerns. Curr Opin Endocrinol, Diabetes Obesity 2007, 14:247-254.
4. Kim H.S., Freedland S.J. Androgen deprivation therapy in prostate cancer: Anticipated side effects and their management. Curr Opin Support Palliat Care 2010, 4:147-152.
5. Nguyen P.L., Chen M.H., Beckman J.A., et al. Influence of androgen deprivation therapy on all-cause mortality in men with high-risk prostate cancer and a history of congestive heart failure or myocardial infarction. Int J Radiat Oncol Biol Phys 2011 Jun 25, [Epub ahead of print].
6. Saylor P.J., Smith M.R. Prostate cancer: How can we improve the health of men who receive ADT?. Nature Rev Urol 2009, 6:529-531.
7. Elliott S., Latini D.M., Walker L.M., et al. Androgen deprivation therapy for prostate cancer: Recommendations to improve quality of life. J Sex Med 2010, 7:2996-3010. ADT Survivorship Working Group.
8. Casey R.G., Corcoran N.M., Larry Goldenberg S. Quality of life issues in men undergoing androgen deprivation therapy: A review. Asian J Andrology 2012 Jan 9, [Epub ahead of print].
9. Shahinian V.B., Kuo Y.F., Freeman J.L., et al. Risk of the "androgen deprivation syndrome" in men receiving androgen deprivation for prostate cancer. Arch Intern Med 2006, 166:465-471.
10. Saini A., Berruti A., Cracco C., et al. Psychological distress in men with prostate cancer receiving adjuvant androgen-deprivation therapy. Urol Oncol 2011 Jul 29, [Epub ahead of print].
11. Faris J.E., Smith M.R. Metabolic sequelae associated with androgen deprivation therapy for prostate cancer. Curr Opin Endocrinol Diabetes Obes 2010, 17:240-246.
12. Keating N.L., O'Malley A.J., Smith M.R. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol 2006, 24:240-246.
13. Lubeck D.P., Grossfeld G.D., Carroll P.R. The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer. Urology 2001, 58:100.
14. Navon L., Morag A. Advanced prostate cancer patients' ways of coping with the hormonal therapy's effect on body, sexuality, and spousal ties. Qual Health Res 2003, 13:1378-1392.
15. Walker L.M., Robinson J.W. The unique needs of couples experiencing androgen deprivation therapy for prostate cancer. J Sex Marital Ther 2010, 36:154-165.
16. Walker L.M., Robinson J.W. A description of heterosexual couples' sexual adjustment to androgen deprivation therapy for prostate cancer. Psycho-Oncology 2011, 20:880-888.
17. Oh S., Meyerowitz B.E., Perez M.A., et al. Need for cognition and psychosocial adjustment in prostate cancer patients and partners. Psychosocial Oncol 2007, 25:1-19.
18. Echlin K.N., Rees C. Information needs and information-seeking behaviours of men with prostate cancer and their partners: A review of the literature. Cancer Nursing 2002, 25:41.
19. Schaffert R., Rusech P., Gugler R., et al. Information needs of patients with prostate cancer. Pronounced differences between individual after diagnosis of localised prostate carcinoma. Urologe A 2011, 50:1089-1094.
20. Wittmann D., Montie J.E., Hamstra D.A., et al. Counseling patients about sexual health when considering post-prostatectomy radiation treatment. Int J Impotence Res 2009, 21:275-284.
21. Hagedoorn M., Sanderman R., Bolks H.N., et al. Distress in couples coping with cancer: A meta-analysis and critical review of role and gender effects. Psychol Bull 2008, 134:1-30.
22. Schumm K., Skea Z., McKee L., et al. 'They're doing surgery on two people': A meta-ethnography of the influences on couples' treatment decision making for prostate cancer. Health Expect 2010, 13:335-349.
23. Seymour-Smith S., Wetherell M. 'What he hasn't told you.': Investigating the micro-politics of gendered support in heterosexual couples' co-constructed accounts of illness. Feminism Psychol 2006, 16:105-127.
24. Merz E.L., Malcarne V.L., Ko C.M., et al. Dyadic concordance among prostate cancer patients and their partners and health-related quality of life: Does it matter?. Psychol Health 2011, 26:651-666.
25. Reese J.B. Coping with sexual concerns after cancer. Curr Opin Oncol 2011, 23:313-321.
26. Rivers B.M., August E.M., Gwede C.K., et al. Psychosocial issues related to sexual functioning among African-American prostate cancer survivors and their spouses. Psycho-Oncology 2011, 20:106-110.
27. Brackett M.A., Mayer J.D., Warne R.M., et al. Emotional intelligence and its relation to everyday behavior. Personality Individual Differences 2004, 36:1387-1402.
28. Arrington M.I. "I don't want to be an artificial man": Narrative reconstruction of sexuality among prostate cancer survivors. Sexuality Culture 2003, Spring:31-58.
29. Grossman M., Zajac J. Management of side effects of androgen deprivation therapy. Endocrinol Metabol Clin North Am 2011, 40:655-671.
30. Moyad M.A., Roach M. Promoting wellness for patients on androgen deprivation therapy: Why using numerous drugs for drug side effects should not be first-line treatment. Urol Clin North Am 2011, 38:303-312.
31. Moyad M. Promoting general health during androgen deprivation therapy (ADT): A rapid 10-step review process for your patients. Urol Oncol 2005, 23:56-64.
32. Haseen F., Murray L.J., Cardwell C.R., et al. The effect of androgen deprivation therapy on body composition in men with prostate cancer: Systematic review and meta-analysis. J Cancer Surviv 2010, 4:128-139.
33. Smith M. Osteoporosis and obesity in men receiving hormone therapy for prostate cancer. J Urol 2004, 172:S52-S57.
34. Murphy R., Wassuersug R.J., Dechman G. The role of exercise in managing the adverse effects of androgen deprivation therapy in men with prostate cancer. Phys Ther Rev 2011, 16:269-277.
35. Heindenreich A. Improving flexibility and quality of life for your patients: A must?. Eur Urol 2009, 8(Suppl):857-862.
36. Templeton H., Coates V. Evaluation of an evidence-based education package for men with prostate cancer on hormonal manipulation therapy. Patient Educ Counsel 2004, 55:55-61.
37. Lebret T., Coloby P., Descotes J.L., et al. Educational tool-kit on diet and exercise: Survey of prostate cancer patients about to receive androgen deprivation therapy. Urology 2010, 76:1434-1439.
38. Beshai S., Dobson K.S., Bockting C.H., et al. Relapse and recurrence prevention in depression: Current research and future prospects. Clin Psych Rev 2011, 31:1349-1360.
39. Robinson J.W., Wassersug R.J., Walker L.M., et al. A preemptive educational intervention to reduce the psychological distress of androgen deprivation therapy on prostate cancer patients and their female partners: Results of an RCT. Psycho-Oncology 2010, 19(Suppl 2).
40. Warkentin K.M., Gray R.E., Wassersug R.J. Restoration of satisfying sex for a castrated cancer patient with complete impotence: A case study. J Sex Marital Ther 2006, 32:389-399.
41. Gilbert E., Ussher J.M., Hawkins Y. Accounts of disruptions to sexuality following cancer: The perspective of informal carers who are partners of a person with cancer. Health: Interdisciplinary J Social Study of Health, Illness and Med 2009, 13:253-260.
42. Mayes J.M., Mouraviev V., Krupski T.L., et al. Concordance in the perception of couples recovering from primary surgical treatment of prostate cancer. Int J Impotence Res 2009, 21:253-260.
43. Sinfield P., Baker R., Camosso-Setinovic J., et al. Men's and carer's experiences of care for prostate cancer: A narrative literature review. Health Expect 2009, 12:301-312.
44. Cushman M.A., Phillips J.L., Wassersug R.J. The language of emasculation: Implications to cancer patients. Int J Men's Health 2010, 9:3-25.
45. Wassersug R.J. On the invisibility of the emasculated. Anthropology Today 2010, 26:1-2.
46. Rot I, Ogah I, Wassersug RJ. The language of prostate cancer treatments and implications on informed decision-making by patients. Unpublished, (Submitted to Sociology of Illness and Health).